» Articles » PMID: 33521301

Pneumococcal Superinfection in COVID-19 Patients: A Series of 5 Cases

Overview
Date 2021 Feb 1
PMID 33521301
Citations 2
Authors
Affiliations
Soon will be listed here.
Abstract

Background: In the context of the COVID-19 pandemic the risk of misdiagnosis of other causes of respiratory infection is likely. In this work we aim to describe the clinical characteristics, treatment and outcome of pneumococcal infection in COVID-19 patients.

Patients And Methods: Every COVID-19 patient presenting with concomitant pneumococcal pneumonia during March 2020 in a tertiary teaching Hospital In Barcelona, Spain.

Results: Five patients with PCR confirmed COVID19 or clinical and radiological suspicion were diagnosed of pneumococcal infection. In all cases chest X-ray were abnormal, with unilateral or bilateral infiltrates. Procalcitonin showed to be not sensitive enough to detect pneumococcal infection. Antibiotherapy was promptly started in all five cases with subsequent satisfactory evolution.

Conclusion: International guidelines do not include the universal screening for bacterial co-infection. Radiological pattern of COVID-19 can be indistinguishable from that of pneumococcus pneumonia and frequency of co-infection is not well stablished, therefore clinicians should be aware of the possible SARS-CoV-2-pneumococcus association to avoid misdiagnosis and delay antibiotic therapy.

Citing Articles

Microbiota and Immunity during Respiratory Infections: Lung and Gut Affair.

Marrella V, Nicchiotti F, Cassani B Int J Mol Sci. 2024; 25(7).

PMID: 38612860 PMC: 11012346. DOI: 10.3390/ijms25074051.


Modeling the crossover behavior of the bacterial infection with the COVID-19 epidemics.

Yu Z, Sohail A, Arif R, Nutini A, Nofal T, Tunc S Results Phys. 2022; 39:105774.

PMID: 35812469 PMC: 9254571. DOI: 10.1016/j.rinp.2022.105774.

References
1.
Lippi G, Simundic A, Plebani M . Potential preanalytical and analytical vulnerabilities in the laboratory diagnosis of coronavirus disease 2019 (COVID-19). Clin Chem Lab Med. 2020; 58(7):1070-1076. DOI: 10.1515/cclm-2020-0285. View

2.
Alhazzani W, Moller M, Arabi Y, Loeb M, Gong M, Fan E . Surviving Sepsis Campaign: guidelines on the management of critically ill adults with Coronavirus Disease 2019 (COVID-19). Intensive Care Med. 2020; 46(5):854-887. PMC: 7101866. DOI: 10.1007/s00134-020-06022-5. View

3.
Domenech de Celles M, Arduin H, Levy-Bruhl D, Georges S, Souty C, Guillemot D . Unraveling the seasonal epidemiology of pneumococcus. Proc Natl Acad Sci U S A. 2019; 116(5):1802-1807. PMC: 6358716. DOI: 10.1073/pnas.1812388116. View

4.
Guan W, Ni Z, Hu Y, Liang W, Ou C, He J . Clinical Characteristics of Coronavirus Disease 2019 in China. N Engl J Med. 2020; 382(18):1708-1720. PMC: 7092819. DOI: 10.1056/NEJMoa2002032. View

5.
Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z . Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020; 395(10229):1054-1062. PMC: 7270627. DOI: 10.1016/S0140-6736(20)30566-3. View